By clicking the "Accept" button or continuing to browse our site, you agree to first-party and session-only cookies being stored on your device to enhance site navigation and analyze site performance and traffic. For more information on our use of cookies, please see our Privacy Policy.
We study the impact of product liability litigation on new product introductions by leading medical device firms. We find that the defendant firms, and other firms to a lesser extent, reduce their propensity to introduce new products in the litigated product categories during litigation years. We also show that changes to features of safety regulation influence the likelihood of litigation. Lastly, we show that the potential welfare loss due to litigation appears relatively contained: the decline in new product introductions is not permanent; it does not spill over beyond the litigated categories and litigation induces firms to develop safer devices.
